- Record: found
- Abstract: not found
- Article: not found
A 12-month evaluation of the CMA-containing oral contraceptive Belara®: efficacy, tolerability and anti-androgenic properties
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
We conducted a postmarketing surveillance study to assess the long-term efficacy and
tolerability of the oral contraceptive Belara (chlormadinone acetate 2.0 mg/ethinylestradiol
0.03 mg) in a normal outpatient setting. Another interest focused on changes in androgen-related
skin and hair disorders.